Literature DB >> 14603198

Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis.

Sara Quenet1, Silvy Laporte, Hervé Décousus, Alain Leizorovicz, Magali Epinat, Patrick Mismetti.   

Abstract

OBJECTIVE: Superficial vein thrombosis may be complicated with venous thromboembolism. We examined factors predictive of venous thromboembolism in superficial vein thrombosis, which, to our knowledge, had not been prospectively studied before. DESIGN AND METHODS: We performed post hoc analysis of the STENOX trial, a prospective randomized controlled trial that investigated various antithrombotic therapies in 427 hospitalized patients with objectively confirmed symptomatic isolated superficial vein thrombosis. The value of various baseline characteristics as predictive factors of venous thrombotic complications at 3 months was studied with logistic regression. Venous thrombotic complications were defined as deep vein thrombosis or pulmonary embolism, or recurrence or proximal extension of superficial vein thrombosis.
RESULTS: Venous thrombotic complications occurred in 78 patients. Independent predictive factors for complications were superficial vein thrombosis of recent onset (odds ratio [OR], 3.01; 95% confidence interval [CI], 1.44-6.27), severe chronic venous insufficiency (OR, 2.75; CI, 1.10-6.89), male gender (OR, 2.17; CI, 1.28-3.68), and history of venous thromboembolism (OR, 2.07; CI 1.06-4.04). Deep vein thrombosis or pulmonary embolism occurred in 19 patients. Only severe chronic venous insufficiency was an independent predictor of this complication (OR, 4.50; CI, 1.30-15.61).
CONCLUSIONS: After symptomatic isolated superficial vein thrombosis, venous thrombotic complications are relatively frequent, and are more likely to occur in men, in patients with a history of venous thromboembolism or with severe chronic venous insufficiency, or in whom superficial vein thrombosis is recent. Knowledge of such predictive factors may be useful for determining appropriate treatment in patients with superficial vein thrombosis and for designing future phase III clinical trials.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14603198     DOI: 10.1016/s0741-5214(03)00607-4

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  8 in total

1.  Lesser saphenous vein thrombosis diagnosed by point-of-care ultrasound in a patient presenting with pulmonary embolism.

Authors:  Natwalee Kittisarapong; Adam Ash; Christopher Raio
Journal:  Intern Emerg Med       Date:  2015-11-05       Impact factor: 3.397

2.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  [Superficial venous thrombosis. A review].

Authors:  C Jeanneret; S Brunner
Journal:  Hautarzt       Date:  2012-08       Impact factor: 0.751

4.  Superficial vein thrombosis treated for 45 days with rivaroxaban versus fondaparinux: rationale and design of the SURPRISE trial.

Authors:  Sebastian Werth; Rupert Bauersachs; Horst Gerlach; Eberhard Rabe; Sebastian Schellong; Jan Beyer-Westendorf
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

5.  Clinical Features and Developing Risks of Saphenous Vein Thrombophlebitis.

Authors:  Hiroto Rikimaru
Journal:  Ann Vasc Dis       Date:  2016-05-04

6.  Incidence of superficial venous thrombosis in primary care and risk of subsequent venous thromboembolic sequelae: a retrospective cohort study performed with routine healthcare data from the Netherlands.

Authors:  Geert-Jan Geersing; Selma Cazemier; Frans Rutten; David A Fitzmaurice; Arno W Hoes
Journal:  BMJ Open       Date:  2018-04-20       Impact factor: 2.692

7.  Guidelines for superficial venous thrombosis.

Authors:  Marcelo José de Almeida; Ana Terezinha Guillaumon; Daniel Miquelin; Edwaldo Edner Joviliano; Ludvig Hafner; Marcone Lima Sobreira; Martin Andreas Geiger; Regina Moura; Selma Raymundo; Winston Bonnetti Yoshida
Journal:  J Vasc Bras       Date:  2019-11-20

Review 8.  Treatment for superficial thrombophlebitis of the leg.

Authors:  Marcello Di Nisio; Iris M Wichers; Saskia Middeldorp
Journal:  Cochrane Database Syst Rev       Date:  2018-02-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.